Dr. Karin L. Andersson, MD

Dr. Andersson practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Andersson's NPI, 1972585511, was assigned on November 18, 2005. Dr. Andersson graduated from Yale School of Medicine in 2000. Dr. Andersson holds Massachusetts license 213884.

Dr. Andersson's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Andersson's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Andersson is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Andersson to 3 more hospitals, 1 community health center and 1 medical group, each named with a free account. Dr. Andersson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Andersson practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Andersson's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Andersson is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Andersson's licenses on file in 5 states: Massachusetts, New Hampshire, Maine, Rhode Island and Pennsylvania.

Dmand AI lists acid reflux, cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, hepatitis c, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Andersson treats.

CMS data shows 501 Medicare services from Dr. Andersson across 10 procedure codes in 2024, for 298 Medicare patients. Medicare paid $44,245 for them.

CMS counts 298 Medicare patients who saw Dr. Andersson in 2024. The largest group is 65 to 74, with 139 patients. 71% of them have high blood pressure, and 68% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Andersson's median patient age at 70, with 60% women.

In 2024, Dr. Andersson wrote 442 Medicare Part D claims for 133 patients. 84% of them were for generic drugs. CMS names the drug for 322 of them, across 12 drugs with 11 or more claims each, at $147,231 in total drug cost. In 2023, CMS named 254 claims across 10 drugs.

Dr. Andersson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Andersson as offering telehealth. CMS counts 26 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Andersson, more than 54% of the clinicians it reports for that procedure.

Dmand AI links 32 papers to Dr. Andersson, published from 2007 to 2020. 2008 was the busiest year, with 2. The most frequent topics are Endometrial Neoplasms, Hepatitis B, Chronic and Laser Therapy. Dr. Andersson has published most often in Acta Obstet Gynecol Scand. Dr. Andersson's most frequent co-authors are Raymond T. Chung, MD, Robert Stephen Brown, MD and Matthew S. Chang, MD.

Dmand AI links Dr. Andersson to 2 clinical trials. Conditions studied include Diabetes Mellitus, Type 2 and Diabetes Mellitus. Open Payments lists research payments to Dr. Andersson that name 1 trial.

CMS Open Payments shows 21 general payments to Dr. Andersson from 3 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $16,800. It also lists 2 research payments totaling $3,200 from 2021 to 2022, naming 1 clinical trial.

Dr. Andersson graduated from Yale School of Medicine in 2000.

Dr. Andersson is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.